Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Effectiveness of Influenza Vaccination and Early Antiviral Treatment in Reducing Pneumonia Risk in Severe Influenza Cases

  • Godoy, Pere|||0000-0002-2896-7286
  • Soldevila, Núria|||0000-0002-1353-5325
  • Martínez, Ana Isabel
  • Godoy, Sofía
  • Jané i Checa, Mireia|||0000-0002-1302-6723
  • Torner, Núria
  • Acosta Argueta, Lesly María|||0000-0002-5859-2120
  • Rius i Gibert, Maria Cristina|||0000-0001-5189-6503
  • Domínguez, Àngela
Introduction: Influenza vaccination may be effective in preventing influenza infection and may reduce the risk of influenza-associated pneumonia. The study aim was to evaluate the effect of influenza vaccination in preventing pneumonia when it failed to prevent influenza hospitalization. Methods: This was a case-control study comparing hospitalized cases of influenza with and without pneumonia in patients aged ≥18 years in 16 hospitals in Catalonia over 10 influenza seasons (2010-11 to 2019-20). Data on sociodemographic, virological characteristics, comorbidities, vaccination history, and antiviral treatment were collected and analysed. The crude odds ratio (OR) and adjusted OR (aOR) with the corresponding 95% confidence interval (CI) values were calculated. Results: In total, 5080 patients hospitalized for severe influenza were included, 63.5% (3224/5080) of whom had pneumonia-mostly men (56.8%; 1830/3224) and mostly in the ≥75 age group (39.3%; 1267/3224)-and of whom 14.0% died (451/3224). Virus A and virus B accounted for 78.1% (2518/3224) and 21.9% (705/3224) of influenza types, respectively. Starting antiviral treatment ≤48 h after symptom onset (aOR = 0.69; 95%CI: 0.53-0.90) and a history of seasonal influenza vaccination (aOR = 0.85; 95%CI: 0.72-0.98) were protective factors in developing pneumonia. Conclusions: Adherence to seasonal influenza vaccination and starting antiviral treatment within 48 h of symptom onset can reduce pneumonia risk in severe influenza cases.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Epidemiology of congenital chagas disease 6 years after implementation of a public health surveillance system, Catalonia, 2010 to 2015

  • Basile, Luca|||0000-0002-4707-2621
  • Ciruela, Pilar|||0000-0003-0842-7220
  • Requena-Méndez, Ana|||0000-0002-4422-241X
  • José Vidal, M. A.
  • Dopico, Eva|||0000-0002-5306-3035
  • Martín Nalda, Andrea|||0000-0002-1715-153X
  • Sulleiro, Elena|||0000-0002-9783-6060
  • Gascon, Joaquim|||0000-0002-5045-1585
  • Jané i Checa, Mireia|||0000-0002-1302-6723
Background: Chagas disease is endemic in Latin America and affects 8 million people worldwide. In 2010, Catalonia introduced systematic public health surveillance to detect and treat congenital Chagas disease. Aim: The objective was to evaluate the health outcomes of the congenital Chagas disease screening programme during the first 6 years (2010-2015) after its introduction in Catalonia. Methods: In a surveillance system, we screened pregnant women and newborns and other children of positive mothers, and treatedChagas-positive newborns and children. Diagnosis was confirmed for pregnant women and children with two positive serological tests and for newborns with microhaematocrit and/or PCR at birth or serology at age 9 months. Results: From 2010 to 2015, the estimated screening coverage rate increased from 68.4% to 88.6%. In this period, 33,469 pregnant women were tested for Trypanosoma cruzi and 937 positive cases were diagnosed. The overall prevalence was 2.8 cases per 100 pregnancies per year (15.8 in Bolivian women).We followed 82.8% of newborns until serological testing at age 9-12 months and 28 were diagnosed withChagas disease (congenital transmission rate: 4.17%). Of 518 siblings, 178 (34.3%) were tested and 14 (7.8%) were positive for T. cruzi. Having other children with Chagas disease and the heart clinical form of Chagas disease were maternal risk factors associated with congenital T. cruzi infection (p < 0.05). Conclusion: The increased screening coverage rate indicates consolidation of the programme in Catalonia. The rate of Chagas disease congenital transmission in Catalonia is in accordance with the range in non-endemic countries.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A Rejection Gene Expression Score in Indication and Surveillance Biopsies Is Associated with Graft Outcome

  • Chamoun, Betty|||0000-0002-4267-2273
  • Caraben, Anna
  • Torres, Irina B.|||0000-0003-3304-0810
  • Sellares, Joana|||0000-0002-0394-8011
  • Jiménez, Raquel
  • Toapanta, Néstor|||0000-0001-5983-6863
  • Cidraque, Ignacio
  • Gabaldón, Alejandra
  • Perelló, Manel|||0000-0003-1859-5279
  • Gonzalo Sanz, Ricardo
  • O'Valle, Francisco|||0000-0001-9207-2287
  • Moreso, Francesc|||0000-0002-7267-3963
  • Seron, Daniel|||0000-0003-2054-653X
Rejection-associated gene expression has been characterized in renal allograft biopsies for cause. The aim is to evaluate rejection gene expression in subclinical rejection and in biopsies with borderline changes or interstitial fibrosis and tubular atrophy (IFTA). We included 96 biopsies. Most differentially expressed genes between normal surveillance biopsies (n = 17) and clinical rejection (n = 12) were obtained. A rejection-associated gene (RAG) score was defined as its geometric mean. The following groups were considered: (a) subclinical rejection (REJ-S, n = 6); (b) borderline changes in biopsies for cause (BL-C, n = 13); (c) borderline changes in surveillance biopsies (BL-S, n = 12); (d) IFTA in biopsies for cause (IFTA-C, n = 20); and (e) IFTA in surveillance biopsies (IFTA-S, n = 16). The outcome variable was death-censored graft loss or glomerular filtration rate decline ≥ 30 % at 2 years. A RAG score containing 109 genes derived from normal and clinical rejection (area under the curve, AUC = 1) was employed to classify the study groups. A positive RAG score was observed in 83% REJ-S, 38% BL-C, 17% BL-S, 25% IFTA-C, and 5% IFTA-S. A positive RAG score was an independent predictor of graft outcome from histological diagnosis (hazard ratio: 3.5 and 95% confidence interval: 1.1-10.9; p = 0.031). A positive RAG score predicts graft outcome in surveillance and for cause biopsies with a less severe phenotype than clinical rejectio.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Norovirus outbreaks in long-term care facilities in Catalonia from 2017 to 2018

  • Parrón, Ignacio|||0000-0002-4875-0236
  • Barrabeig, Irene|||0000-0003-4789-7620
  • Alsedà, Miquel|||0000-0003-4008-3616
  • Rius i Gibert, Maria Cristina|||0000-0001-5189-6503
  • Cornejo-Sánchez, Thais|||0000-0002-1350-0413
  • Jané i Checa, Mireia|||0000-0002-1302-6723
  • Pérez, Cristina
  • Guix, Susana|||0000-0002-1588-3198
  • Domínguez, Ángela|||0000-0003-0219-1907
Norovirus is the leading cause of outbreaks of acute viral gastroenteritis. We carried out this study to investigate outbreaks in long-term care facilities reported in 2017 and 2018 in Catalonia (Spain). The characteristics of the centers, exposed persons and the genogroups responsible were analyzed. Viral loads were estimated. The attack rate (AR) of the outbreaks studied, and the rate ratio (RR) and the odds ratio (OR) and their 95% confidence intervals as measures of association were calculated. The mean cycle thresholds were compared using the t-test for independent means. We included 30 outbreaks (4631 exposed people). The global AR was 25.93%. The RR of residents vs. staff was 2.28 (95% CI 2.0-2.6). The RR between AR in residents with total or severe dependence vs. residents with moderate, low or no-dependence was 1.23 (95% CI 1.05-1.45). The AR were higher in smaller centers than in larger ones (38.47% vs. 19.25% and RR 2; 95% CI 1.82-2.2). GII was responsible for 70% of outbreaks. No association was found between the genogroup and presenting symptoms (OR 0.96; 95% CI 0.41-2.26). Viral loads were higher in symptomatic than in asymptomatic patients (p = 0.001).
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A waterborne gastroenteritis outbreak caused by a gii norovirus in a holiday camp in catalonia (Spain), 2017

  • Carol Torrades, Monica
  • Guadalupe-Fernández, Víctor|||0000-0002-1074-5597
  • Rius i Gibert, Maria Cristina|||0000-0001-5189-6503
  • Soldevila, Nuria
  • Razquin, Efrén
  • Guix, Susana|||0000-0002-1588-3198
  • Domínguez, Ángela|||0000-0003-0219-1907
On 2 February 2017, Epidemiological Surveillance Services were notified of an outbreak of acute gastroenteritis (AGE) among schoolchildren who had taken part of a school trip from 30 January to 3 February 2017 at a holiday camp in Catalonia. A retrospective cohort study was performed to identify the causative agent, estimate the magnitude of the outbreak and identify its source, as well as to determine the route of transmission. Data collected by standardised questionnaires identified 41 episodes of AGE among 174 individuals who attended the camp. Cases had mainly symptoms of abdominal pain (73.8%), nausea (64.3%), vomiting (54.8%), diarrhoea (45.2%) and headache (42.9%). Consumption of water was associated with gastroenteritis (crude RR: 1.72, 95%CI: 1.01-2.92; adjusted RR: 1.88, 95%CI 1.03-3.56). NoV GII was detected in faeces (5 out of 13) and water samples. Additionally, faecal indicator bacteria and protozoa were detected in water samples. The outbreak showed a high attack rate and was caused by a natural water fountain not properly treated and not monitored for safety quality. There could have been a discharge of wastewater at a point close to the fountain; however, the source of contamination of the water could not be identified. Health education may be useful to eliminate risks associated with the consumption of untreated water from natural fountains.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Influenza vaccine effectiveness in preventing severe outcomes in patients hospitalized with laboratory-confirmed influenza during the 2017-2018 season. A retrospective cohort study in catalonia (spain)

  • Acosta Argueta, Lesly María|||0000-0002-5859-2120
  • Torner, Nuria|||0000-0003-0143-5295
  • Martínez, Ana
  • Ayneto, Xavier
  • Rius i Gibert, Maria Cristina|||0000-0001-5189-6503
  • Jané i Checa, Mireia|||0000-0002-1302-6723
  • Domínguez, Ángela|||0000-0003-0219-1907
  • Soldevila, Nuria
Seasonal influenza is a common cause of hospital admission, especially in older people and those with comorbidities. The objective of this study was to determine influenza vaccine effectiveness (VE) in preventing intensive care admissions and shortening the length of stay (LOS) in hospitalized laboratory-confirmed influenza cases (HLCI) in Catalonia (Spain). A retrospective cohort study was carried out during the 2017-2018 season in HLCI aged ≥18 years from 14 public hospitals. Differences in means and proportions were assessed using a t-test or a chi-square test as necessary and the differences were quantified using standardized effect measures: Cohen's d for quantitative and Cohen's w for categorical variables. Adjusted influenza vaccine effectiveness in preventing severity was estimated by multivariate logistic regression where the adjusted VE = (1 - adjusted odds ratio) · 100%; adjustment was also made using the propensity score. We analyzed 1414 HLCI aged ≥18 years; 465 (33%) were vaccinated, of whom 437 (94%) were aged ≥60 years, 269 (57.8%) were male and 295 (63.4%) were positive for influenza type B. ICU admission was required in 214 (15.1%) cases. There were 141/1118 (12.6%) ICU admissions in patients aged ≥60 years and 73/296 (24.7%) in those aged <60 years (p < 0.001). The mean LOS and ICU LOS did not differ significantly between vaccinated and unvaccinated patients. There were 52/465 (11.2%) ICU admissions in vaccinated cases vs. 162/949 (17.1%) in unvaccinated cases. Patients admitted to the ICU had a longer hospital LOS (mean: 22.4 [SD 20.3] days) than those who were not (mean: 11.1 [SD 14.4] days); p < 0.001. Overall, vaccination was associated with a lower risk of ICU admission. Taking virus types A and B together, the estimated adjusted VE in preventing ICU admission was 31% (95% CI 1-52; p = 0.04). When stratified by viral type, the aVE was 40% for type A (95% CI-11-68; p = 0.09) and 25% for type B (95% CI-18-52; p = 0.21). Annual influenza vaccination may prevent ICU admission in cases of HLCI. A non-significantly shorter mean hospital stay was observed in vaccinated cases. Our results support the need to increase vaccination uptake and public perception of the benefits of influenza vaccination in groups at a higher risk of hospitalization and severe outcomes.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Behavior of hospitalized severe influenza cases according to the outcome variable in Catalonia, Spain, during the 2017-2018 season

  • Soldevila, Núria|||0000-0002-1353-5325
  • Acosta Argueta, Lesly María|||0000-0002-5859-2120
  • Martínez, Ana
  • Godoy, Pere|||0000-0002-2896-7286
  • Torner, Nuria|||0000-0003-0143-5295
  • Rius i Gibert, Maria Cristina|||0000-0001-5189-6503
  • Jané i Checa, Mireia|||0000-0002-1302-6723
  • Domínguez, Ángela|||0000-0003-0219-1907
  • Alsedà, Miquel|||0000-0003-4008-3616
  • Álvarez, Josep
  • Arias, César
  • Balaña, Pilar Jorgina
  • Barrabeig, Irene|||0000-0003-4789-7620
  • Camps, Neus
  • Carol Torrades, Monica
  • Ferràs, Joaquim
  • Ferrús, Glòria
  • Follia, Nuria
  • Bach Foradada, Pilar
  • Minguell, Sofia
  • Parrón, Ignacio|||0000-0002-4875-0236
  • Plasència, Elsa
  • Sala-Farré, Maria Rosa
  • Torra Balcells, Roser|||0000-0001-8714-2332
  • Torres, J.
  • Marcos, María Ángeles|||0000-0002-5019-4873
  • Mosquera, Maria del Mar|||0000-0001-5863-7424
  • Vilella, Anna|||0000-0002-2329-676X
  • Antón Pagarolas, Andrés, 1976-|||0000-0002-1476-0815
  • Pumarola Suñé, Tomàs|||0000-0002-5171-7461
  • Campins Martí, Magda|||0000-0002-8841-6195
  • Garciá, D.
  • Oller Perez-Hita, A.
  • Espejo, Elena|||0000-0001-9018-7515
  • Freixas, Núria
  • Riera Garcia, Montserrat
  • Maraver, Encarna
  • Mas, Dolors
  • Pérez, Rafael
  • Rebull Fatsini, Josep|||0000-0002-1460-8290
  • Pou, J.
  • García-Pardo, Graciano|||0000-0003-0274-6001
  • Olona, Montserrat|||0000-0001-5303-9361
  • Barcenilla, Fernando
  • Castellana, Dolors
  • Navarro Rubio, Gemma|||0000-0002-7195-9046
  • Force, Lluís
  • Mòdol-Deltell, J.M.
  • Alvarez, A.
  • Torrel, J.M.
Influenza is an important cause of severe illness and death among patients with underlying medical conditions and in the elderly. The aim of this study was to investigate factors associated with ICU admission and death in patients hospitalized with severe laboratory-confirmed influenza during the 2017-2018 season in Catalonia. An observational epidemiological case-to-case study was carried out. Reported cases of severe laboratory-confirmed influenza requiring hospitalization in 2017-2018 influenza season were included. Mixed-effects regression analysis was used to estimate the factors associated with ICU admission and death. A total of 1306 cases of hospitalized severe influenza cases were included, of whom 175 (13.4%) died and 217 (16.6%) were ICU admitted. Age 65-74 years and ≥ 75 years and having ≥ 2 comorbidities were positively associated with death (aOR 3.19; 95%CI 1.19-8.50, aOR 6.95, 95%CI 2.76-1.80 and aOR 1.99; 95%CI 1.12-3.52, respectively). Neuraminidase inhibitor treatment and pneumonia were negatively associated with death. The 65-74 years and ≥ 75 years age groups were negatively associated with ICU admission (aOR 0.41; 95%CI 0.23-0.74 and aOR 0.30; 95%CI 0.17-0.53, respectively). A factor positively associated with ICU admission was neuraminidase inhibitor treatment. Our results support the need to investigate the worst outcomes of hospitalized severe cases, distinguishing between death and ICU admission.